PPG-0.3

About

PPG-0.3 contains Voglibose, an alpha-glucosidase inhibitor, which is an oral antidiabetic drug specifically designed to manage post-prandial hyperglycemia, or the rapid rise in blood sugar levels that occurs after meals, in patients with type 2 diabetes mellitus. Its mechanism of action involves reversibly inhibiting the alpha-glucosidase enzymes located in the brush border of the small intestine. These enzymes are responsible for breaking down complex carbohydrates into simpler sugars that can be absorbed into the bloodstream. By delaying this digestion and absorption process, Voglibose effectively blunts the post-meal glucose spike, leading to a smoother blood glucose profile. It is often used as an adjunct to diet and exercise, or in combination with other antidiabetic agents, to achieve better overall glycemic control and reduce the risk of long-term diabetic complications.

Uses

• Management of type 2 diabetes mellitus.
• To control post-prandial hyperglycemia.
• As an adjunct to diet and exercise.
• In combination with other oral antidiabetic agents.

Directions For Use

Take orally immediately before or with the first bite of each main meal, as directed by your physician.

Benefits

• Specifically targets post-meal blood sugar spikes.
• Reduces overall blood glucose levels.
• Helps prevent long-term diabetic complications.
• Does not cause weight gain.
• Low risk of hypoglycemia when used alone.
• Improves glycemic control.

Side Effects

• Flatulence
• Abdominal distension
• Diarrhea
• Abdominal pain
• Nausea
• Vomiting
• Indigestion
• Constipation
• Skin rash (rare)
• Hepatitis (very rare)
• Increased liver enzymes (rare)
• Hypoglycemia (when used with sulfonylureas or insulin)

Safety Measures

• Alcohol - No specific contraindication, but excessive alcohol can affect blood sugar control.
• Pregnancy - Not recommended during pregnancy due to insufficient safety data. Consult your doctor for alternative treatments.
• Breastfeeding - Not recommended during breastfeeding as it is unknown if it passes into breast milk.
• Liver - Contraindicated in patients with severe liver impairment due to potential for liver enzyme elevation.
• Kidney - Use with caution in patients with moderate to severe renal impairment; dose adjustment may be necessary.
• Lung - Generally safe for use in patients with lung conditions; no specific precautions related to lung function.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.